Vancomycini hydrochloridum CAS:1404-93-9
Vancomycin hydrochloridum est medicamentum antibioticum praecipue ad curandas infectiones graves a bacteriis Gram-positivis quae aliis antibioticis resistentes sunt causatas adhibetur. Typice intravenose administratur propter absorptionem oralem malam.
Usus principalis vancomycini hydrochloridi est in curatione infectionum a Staphylococco aureo methicillino resistente (MRSA) aliisque bacteriis Gram-positivis multiresistentibus causatarum. Praecipue efficax est contra infectiones graves sicut infectiones sanguinis, endocarditidem, infectiones ossium et articulationum, et pneumoniam.
Vancomycin hydrochloridum operatur per inhibitionem synthesis parietum cellularum in his bacteriis, quod tandem ad mortem earum ducit. Utile est praesertim in casibus ubi alia antibiotica propter resistentiam non efficacia esse possunt..
| Compositio | C66H76Cl3N9O24 |
| Examen | 99% |
| Aspectus | Pulvis albus |
| Numerus CAS | 1404-93-9 |
| Sarcinatio | Parvus et moles |
| Tempus Vitae | Biennium |
| Depositorium | In loco frigido et sicco servandum |
| Certificatio | ISO. |




![4-[[2-(N-Methylcarbamoyl)-4-pyridyl]oxy]anilinum CAS:284462-37-9](https://cdn.globalso.com/xindaobiotech/K@NIE7HBAEP6E7J7DS356.png)
![(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinonum CAS:189028-93-1](https://cdn.globalso.com/xindaobiotech/10WCKQ6EGR3DADJD9G131.png)


